Alaska Urological Institute

Anchorage, Alaska 99503

0 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Transitional Cell, Hodgkin Disease, Metastatic Castration Resistant Prostate Cancer (mCRPC), Non-muscle Invasive Bladder Cancer (NMIBC), Peripheral T Cell Lymphoma, Renal Pelvis Neoplasms, Ureteral Neoplasms, Urethral Neoplasms, Urinary Bladder Neoplasms, Urologic Neoplasms, Urothelial Cancer

Studies at this site

• A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer — Stopped early
• ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
• A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer — Completed
• A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) — Completed
• Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC — Stopped early